Key result
HeartLogic-guided preemptive HF management yields a ~6% unplanned hospitalization rate over 12 months.
Why the study?
HeartLogic predicts heart failure episodes via a remotely monitored index to aid proactive congestion treatment, but the efficacy and safety of preemptive management using this index required assessment.
Does preemptive HF management guided by the HeartLogic index reduce unscheduled HF hospitalizations in heart failure patients with implanted cardioverter defibrillators?
Cohort (n=310)
Single-blind (adjudication committee)
Yes
Does preemptive HF management guided by the HeartLogic index reduce unscheduled HF hospitalizations in heart failure patients with implanted cardioverter defibrillators?
Preemptive heart failure management guided by the HeartLogic index in patients with implanted devices is associated with low rates of unplanned hospitalizations and adverse events.
Answers are grounded in this paper and cite their sources.
Low unplanned HF hospitalizations observed with HeartLogic monitoring; supports consensus but leaves open randomized confirmation.
Background Heart failure (HF) affects 64 million people worldwide, posing a significant societal burden through high mortality rates, frequent rehospitalizations, and economic costs. HeartLogic, an algorithm in implanted devices, predicts HF episodes via a remotely monitored index, aiding proactive congestion treatment to prevent acute decompensation. This study assessed the efficacy and safety of preemptive HF management using the HeartLogic index. Methods The HeartLogic France Cohort Study is a prospective multicenter investigation involving 310 heart failure (HF) patients (LVEF ≤40% or clinical HF history with NT-proBNP ≥450 ng/L) with implanted cardioverter defibrillators enrolled from 10 French centers. The HeartLogic index was monitored weekly for 12 months. When the index reached ≥16, the local investigator contacted the patient to assess and adjust HF treatment as needed. The primary endpoint was unscheduled HF hospitalization. The safety of the HeartLogic-triggered strategy for initiating or increasing diuretic therapy was also evaluated. An independent committee, blinded to study conditions, adjudicated hospitalizations and deaths. Results The mean age of the participants was 64.9 ± 9.9 years, with 83.5% male. The mean LVEF was 30.7 ± 8.3%, and the median NT-proBNP level was 1000 (Q1-Q3 394–2299) ng/L. Ischemic cardiomyopathy was present in 61.2% of the patients, and 52.8% had a cardiac resynchronization therapy device. During the 12-month follow-up period, 388 alerts occurred in 158 patients (1.2 alerts/patient/year globally). A total of 24 unplanned HF hospitalizations occurred in 19 (6.1%) patients, and 18 (5.8%) patients died, of whom five succumbed to HF. Two patients experienced a creatinine elevation of at least 30% and two patients symptoms of hypotension. No cases of dyskalaemia or hyponatremia were detected. Conclusions In this study, preemptive HF management guided by the HeartLogic index was associated with low rates of unplanned hospitalizations and adverse events over a 12-month follow-up period.unplanned HF hospitalisations
No takes yet. Share an insight, caveat, or question.
Garcia et al. (2025) conducted a cohort in Heart failure (n=310). Preemptive HF management guided by the HeartLogic index was evaluated on Unscheduled HF hospitalization. Preemptive heart failure management guided by the HeartLogic index was associated with a 6.1% rate of unplanned heart failure hospitalizations over a 12-month follow-up period.
Synapse has enriched 10 related papers. Consider them for comparative context: